TET2 and colorectal carcinoma: In keeping with bisulfite sequencing data, we have not observed DNA methylation within TET2 (chr4: 106 067,537–106,067 735) and TET3 (ch42: 74,211,418–74,211 584) promoter regions in 113 patients with CRC (Fig. 3b, c).